drugdeliverybusiness4h
Medtronic says it has next-gen insulin pumps on the way, more to come from diabetes business
The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.
BD expands syringe, needle production capacity in Nebraska and Connecticut
BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.